Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Given currently inadequate evidence to support that COVID-19 patients with G6PD deficiency have a worse prognosis in terms of mortality, severity, and rate of hospitalization [11], a larger scale study should be performed that encompasses different ages, ethnicity, gender, and more importantly the disease-alleles (hemizygous, homozygous or heterozygous) with consideration of G6PD deficiency variants
PubMed Bockmann M, Drosten C, Panning M, Kaufmann AM (2023)
New mechanisms, delivery systems, and therapeutic applications are likely to expand the role of peptides in healthcare
The lack of LCMV-specific antibodies in our mutant mice could be caused by either a failure of the GC reaction or a defect in antibody production
US$ 29.74
US$ 21.45
US$ 27.28
US$ 27.12
